Health Sciences Institute e-Alert Archives

Our daily e-letter, known as e-Alert, delivers health news—before anyone else. From overlooked studies to underground cures, it’s all here. Catch up on the insights that matter most.

Every weekday, our FREE e-Alert delivers urgent health breakthroughs and hidden dangers—before they hit the headlines.

Not signed up yet? Join 500,000+ readers worldwide by using the sign-up box below.

FILTERS
applied to search results for “Prescription Drug and FDA”

YEAR

CATEGORY

Browse the FULL e-Alert Archive using the filters in this section, or search for a specific topic below:


Search Results for “Prescription Drug and FDA” (493 results found)

Only one way to describe the FDA black box warning system: a dangerous mess

November 29, 2011 Here's how FDA officials warn you that you might be risking a coma, or fatal kidney damage, or some other horrendous adverse event linked to the drug you're about to take: They take a fine-line marker and draw a box around the warning... that's what the FDA considers a "black... Read More >

Categories: black box warning drug drug information drug label information FDA information insert online discussions SSRIs warning

You’ll never guess who’s touting the beneficial effects of glucosamine

November 22, 2011 If I told you that a company was spending marketing and PR dollars to fight for the right to explain the beneficial effects of glucosamine -- the natural supplement that helps rebuild cartilage and provide support for healthy, flexible joints -- who would you think I was talking about? ...How... Read More >

Categories: FDA glucosamin joints Merck natural supplement normal joint health prescription drugs rebuild cartilage Seven Seas

When two drugs are repackaged as a combo drug, side effect risks soar

October 19, 2011 I thought of that hilarious parody while reading about the newest FDA drug approval, which is not hilarious at all. The drug has a catchy name: Juvisync. It combines the statin Zocor with Januvia, a type 2 diabetes drug. So is it a cholesterol drug that controls blood sugar, or... Read More >

Categories: acute pancreatitis blood sugar blood-sugar-lowering drug cholesterol drug FDA FDA drug approval floor wax Januvia Juvisync kidney impairment LDL cholesterol Lipitor Merck potential disaster prescription drugs safety information side effects statin type 2 diabetes type 2 diabetes drug Zocor

Who would dare prey on the anxieties of pregnant women? Big Pharma, of course

October 13, 2011 Imagine the tension, the worry, and the dread that must fill any young couple when they're informed that their unborn child is at high risk of premature birth. Now imagine drug company executives who are willing to hold hostage the health of at-risk unborn fetuses in return for an exorbitant... Read More >

Categories: 17P American Academy of Pediatrics drug company executives drug company ransom FDA fear hold hostage hormone therapy KV Pharmaceutical Makena March of Dimes obstetrician patients premature birth prescriptions preterm births preterm pregnancy progesterone

Millions are addicted to this legal drug and don’t even know it

October 6, 2011 They may not be hanging out on "the corner" or look like your typical druggie, but there are millions of people -- people just like you and me -- who are addicted to a drug, and they're completely unaware of it... Read More >

Categories: acid reflux addicted to a drug addiction antacid black box warnings developing dependency drug drug companies FDA heartburn hooked legal drugs lifesaver longtime use magnesium PPI drug prescription PPI drugs Prilosec proton pump inhibitor drugs serious health risks stomach acid

When doctors start prescribing, side effects (and kidney risks) begin to add up

September 20, 2011 Would you like to go for a ride on the prescription drug roller coaster? No? I don't blame you -- I wouldn't either. But millions of patients do, whether they really want to or not. Their doctors prescribe a drug for this and a drug for that, and pretty soon... Read More >

Categories: acute interstitial nephritis acute kidney failure Arthritis bone fracture risk calcium-rich foods cholesterol lowering statin drugs dialysis drug drug roller coaster heartburn high cholesterol kidney damage kidney threats kidneys moderate-to-severe kidney impairment National Kidney Foundation osteoporosis post-menopausal PPI drugs prescription drug progressive kidney damage Reclast side effects unexpected interactions vitamin d weight-bearing exercises zoledronic acid Zometa

Mainstream medicine’s dirty little secret that most people will never know

August 25, 2011 Years ago, when I first started writing about alternative healthcare, I was stunned to learn that synthetic drugs can deplete your body of vitamins and minerals. I think it's safe to say, most people are completely unaware that while you're taking a drug to treat a condition, you're at least... Read More >

Categories: acid reflux alternative healthcare arrhythmias cognitive decline convulsions depletion Diabetes FDA healthy bones heartburn irregular heartbeat low serum magnesium levels magnesium deficiency magnesium levels magnesium supplementation muscle spasm Nexium Prevacid Prilosec proton-pump inhibitors (PPIs) seizures synthetic drugs tetany type 2 diabetes vitamins and minerals

FDA confirms type 2 diabetes drug link to bladder cancer

June 22, 2011 As I told you earlier this week, France's drug authority recently told doctors to stop prescribing Actos based on a new study that links the type 2 diabetes drug to bladder cancer risk. Here in the U.S., FDA officials are not quite as cautious... Read More >

Categories: Actos bladder cancer FDA pioglitazone type 2 diabetes

Type 2 diabetics must avoid the Actos trap

June 20, 2011 You see, last year the FDA helped set a trap for type 2 diabetics with this shocking report: Over the past decade, it is estimated that 48,000 patients experienced stroke, heart failure, or death because they used Avandia instead of Actos (two best selling type 2 diabetes drugs... Read More >

Categories: Actos Avandia GlaxoSmithKline Takeda Pharmaceuticals type 2 diabetes

Muscle damage link to statin drugs goes deeper than we thought

June 16, 2011 Last spring, the FDA first warned that the highest dose of Zocor (a statin drug) may increase the risk of muscle damage. Now, more than a FULL YEAR later, the agency has finally gotten around to telling Merck (the maker of Zocor) to change the drug's label to show that... Read More >

Categories: arterial plaque Cataracts FDA kidney failure Lipitor liver damage memory loss Merck statin drugs type 2 diabetes Vytorin Zocor
Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >